Get started
Work

Abstract PS1-11-29: Factors predicting the effictiveness of CDK4/6 inhibitor rechallenge following progression on first-line endocrine therapy combined with a CDK4/6 inhibitor in ER+ metastatic breast cancer in the French ESME Database

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-ps1-11-29
Authors: T. PAPAZYAN, A. Lusque, A. Mailliez, T. Bachelot, T. Grinda, A. Goncalves, E. Brain, A. Savoye, M. Arnedos, C. Levy, I. Desmoulins, T. De La Motte Rouge, C. Pflumio, M. Mouret-Reynier, V. Massard, M. Leheurteur, L. Bosquet, W. Jacot, M. Campone, J. Frenel
Institutions: Institut universitaire du cancer de Toulouse Oncopole, Centre Oscar Lambret, Centre Léon Bérard, Institut Gustave Roussy, Institut Curie, Institut Jean Godinot, Institut Bergonié, Centre François Baclesse, Centre Georges François Leclerc, Centre Eugène Marquis, Institut de Cancérologie Strasbourg, Centre Jean Perrin, Institut de Cancérologie de Lorraine, Centre Henri Becquerel, UniCancer Group
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7129435532
Cites:
Cited by:
Related to: